Jianhong Wang
senior director of clinical pharmacology and dmpk at Cortexyme - South San Francisco, CA, US
Jianhong Wang's Colleagues at Cortexyme
Florian Ermini
Associate Director, In Vivo Pharmacology and Translational Biology
Jianhong Wang's Contact Details
800-952-5210
Cortexyme
Jianhong Wang's Company Details
Cortexyme is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimer's and other degenerative diseases. Cortexyme is targeting a specific pathogen found in the brain of Alzheimer's patients that causes neurodegeneration and other pathology in animal models. Cortexyme's lead small molecule, atuzaginstat (COR388), has advanced through Phase Ib and is currently the subject of a Phase 2/3 GAIN clinical trial in mild to moderate Alzheimer's disease patients.